Related Experiment Video
Updated: Jun 26, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Hypertriglyceridemia: phenomics and genomics.
Robert A Hegele1, Rebecca L Pollex
1Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N6A 5K8, Canada. hegele@robarts.ca
Molecular and Cellular Biochemistry
|January 9, 2009
Summary
Genetic factors significantly influence high triglyceride levels (hypertriglyceridemia), a condition linked to heart disease and metabolic syndrome. Research identifies both rare and common genetic variants contributing to triglyceride variation.
Area of Science:
- Genetics
- Metabolic Disorders
- Cardiovascular Disease Risk
Background:
- Hypertriglyceridemia is a prevalent metabolic condition associated with increased risk of atherosclerosis, metabolic syndrome, and pancreatitis.
- Understanding the genetic underpinnings of hypertriglyceridemia is crucial for risk stratification and therapeutic strategies.
Purpose of the Study:
- To explore the genetic determinants of plasma triglyceride concentrations.
- To investigate the contribution of both rare and common genetic variants to triglyceride variation.
- To assess the potential of phenomic evaluation in understanding genotype-phenotype correlations in hypertriglyceridemia.
Main Methods:
- Hierarchical cluster analysis of clinical and biochemical features (Frederickson hyperlipoproteinemia types).
- High-throughput resequencing of individuals with extreme plasma triglyceride concentrations.
- Genome-wide marker analysis in normolipidemic subjects.
Main Results:
- Both rare genetic variants with large effects and common variants with moderate effects explain a significant proportion of triglyceride variation.
- Recent genome-wide studies have identified additional genetic determinants, though often with small effect sizes.
- Genetic factors play a substantial role in determining plasma triglyceride levels.
Conclusions:
- Genetic variations are key contributors to plasma triglyceride levels.
- Further phenomic evaluation may enhance understanding of genotype-phenotype relationships and treatment responses in hypertriglyceridemia.
- Identifying genetic determinants aids in understanding atherosclerosis and metabolic syndrome risks.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...